Published in Drugs on February 01, 1989
Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev (2006) 5.08
Study of the interaction of DNA with cisplatin and other Pd(II) and Pt(II) complexes by atomic force microscopy. Nucleic Acids Res (1998) 0.98
Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats. Br J Cancer (1993) 0.82
Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support. Br J Cancer (1996) 0.80
Antitumor and antimetastasis effects of carboplatin liposomes with polyethylene glycol-2000 on SGC-7901 gastric cell-bearing nude mice. Oncol Lett (2014) 0.80
Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials. Ann Oncol (2009) 0.78
OTOTOXIC EFFECTS OF CARBOPLATIN IN ORGANOTYPIC CULTURES IN CHINCHILLAS AND RATS. J Otol (2012) 0.77
Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin. ACS Chem Neurosci (2016) 0.75
A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation. Br J Cancer (2001) 0.75
The excretion of vitamin C in human urine and its dependence on the dietary intake. Biochem J (1933) 22.45
Complementary medicine in Europe. BMJ (1994) 7.70
Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev (1993) 4.69
Generalized equations for predicting body density of women. Med Sci Sports Exerc (1980) 4.21
A comparative analysis of four protocols for maximal treadmill stress testing. Am Heart J (1976) 3.43
Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs (1982) 3.34
Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer (2001) 3.21
Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs (1986) 2.72
Estimation of VO2max from a one-mile track walk, gender, age, and body weight. Med Sci Sports Exerc (1987) 2.34
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1988) 2.27
Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs (1980) 2.26
Comparative analysis of physiologic responses to three different maximal graded exercise test protocols in healthy women. Am Heart J (1982) 2.23
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension. Drugs (1977) 2.17
Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use. Drugs (1978) 2.12
Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs (1983) 2.02
Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs (1982) 1.87
Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs (1990) 1.83
miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene (2010) 1.82
Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs (1995) 1.81
Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs (1997) 1.81
Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1986) 1.75
Race, presenting signs and symptoms, use of carotid artery imaging, and appropriateness of carotid endarterectomy. Stroke (1999) 1.73
Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential. Drugs (1993) 1.73
Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Drugs (1978) 1.72
Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1983) 1.71
Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs (1980) 1.67
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1984) 1.65
Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs (1981) 1.64
Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs (1984) 1.64
The demand for eating disorder care. An epidemiological study using the general practice research database. Br J Psychiatry (1996) 1.63
Regulation of growth and metabolism by imprinted genes. Cytogenet Genome Res (2006) 1.63
Developmental and behavioural outcome in obstetric brachial plexus palsy. J Hand Surg Br (2000) 1.63
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs (1980) 1.59
Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs (1981) 1.55
CpG methylation regulates the Igf2/H19 insulator. Curr Biol (2001) 1.55
Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs (1986) 1.53
Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1984) 1.52
Nefopam: a review of its pharmacological properties and therapeutic efficacy. Drugs (1980) 1.51
Fish shoal composition: mechanisms and constraints. Proc Biol Sci (2000) 1.50
Epidemiological and surgical aspects of urogenital fistulae: a review of 25 years' experience in southeast Nigeria. Int Urogynecol J Pelvic Floor Dysfunct (1998) 1.50
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature. Prostate Cancer Prostatic Dis (2011) 1.50
Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs (1978) 1.48
Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs (1991) 1.45
Monocular and binocular depth discrimination thresholds. Optom Vis Sci (1999) 1.45
Labetalol: a review of its pharmacology and therapeutic use in hypertension. Drugs (1978) 1.44
Chronic psychological effects of exercise and exercise plus cognitive strategies. Med Sci Sports Exerc (1995) 1.44
Nabilone. A preliminary review of its pharmacological properties and therapeutic use. Drugs (1985) 1.44
Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs (1994) 1.44
Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections. Drugs (1980) 1.43
T lymphocyte subpopulations in anorexia nervosa and refeeding. Clin Immunol Immunopathol (1997) 1.43
Histological observations of bovine tuberculosis in lung and lymph node tissues from British deer. Vet J (2007) 1.42
Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea. Drugs (1978) 1.40
Arterial complications of the thoracic outlet syndrome: fifty-five operative cases. J Vasc Surg (1989) 1.39
Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting. Pharmacoeconomics (1996) 1.39
Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs (1986) 1.39
Access of the black urban elderly to medical care. J Natl Med Assoc (1983) 1.39
Lessons to be learned: a case study approach. An unusual case of alveolar deposition from swallowing metallic mercury in an attempt at self-poisoning. J R Soc Promot Health (1998) 1.38
Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs (1978) 1.37
Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1990) 1.36
Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy. Drugs (1981) 1.33
Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs (1987) 1.33
Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs (1979) 1.32
Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs (1986) 1.31
Meptazinol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs (1985) 1.31
Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs (1990) 1.29
Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1985) 1.29
Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1979) 1.29
RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc Natl Acad Sci U S A (1996) 1.27
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1984) 1.26
Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia. Drugs (1990) 1.23
Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer. Drugs (1978) 1.23
Clobazam: a review of its pharmacological properties and therapeutic use in anxiety. Drugs (1980) 1.22
Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II) Br J Cancer (1995) 1.22
Fenoterol: a review of its pharmacological properties and therapeutic efficacy in asthma. Drugs (1978) 1.22
Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs (1982) 1.22
Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic. Drugs (1988) 1.19
Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care. Neurology (2001) 1.19
Determining which automatic digital blood pressure device performs adequately: a systematic review. J Hum Hypertens (2010) 1.18
Folate status and requirement in pregnancy. Br Med J (1968) 1.18
Studies of cervical mucus and serum from infertile women. J Obstet Gynaecol Br Commonw (1968) 1.17
Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure. Drugs (1983) 1.17
Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs (1991) 1.17
Walking for health and fitness. JAMA (1988) 1.17
Development of a single-stage submaximal treadmill walking test. Med Sci Sports Exerc (1991) 1.16
Congenital brachial palsy: incidence, causes, and outcome in the United Kingdom and Republic of Ireland. Arch Dis Child Fetal Neonatal Ed (2003) 1.15
Econazole: a review of its antifungal activity and therapeutic efficacy. Drugs (1978) 1.14
The influence of radiotherapy on capsule formation and aesthetic outcome after immediate breast reconstruction using biodimensional anatomical expander implants. J Plast Reconstr Aesthet Surg (2006) 1.13
Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1985) 1.13
Butorphanol: a review of its pharmacological properties and therapeutic efficacy. Drugs (1978) 1.13
Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs (1981) 1.13
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy. Drugs (1982) 1.12
Piroxicam: a review of its pharmacological properties and therapeutic efficacy. Drugs (1981) 1.11
Discriminating translation of insulin-like growth factor-II (IGF-II) during mouse embryogenesis. Mol Reprod Dev (1994) 1.11
Ribavirin and inosiplex: a review of their present status in viral diseases. Drugs (1981) 1.11
Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs (1984) 1.11